Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer. Issue 2 (February 2022)

Record Type:
Journal Article
Title:
Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer. Issue 2 (February 2022)
Main Title:
Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
Authors:
Ligumsky, Hagai
Dor, Herut
Etan, Tal
Golomb, Inbal
Nikolaevski-Berlin, Alla
Greenberg, Inbal
Halperin, Tamar
Angel, Yoel
Henig, Oryan
Spitzer, Avishay
Slobodkin, Marina
Wolf, Ido
Abstract:
Is Part Of:
Lancet oncology. Volume 23:Issue 2(2022)
Journal:
Lancet oncology
Issue:
Volume 23:Issue 2(2022)
Issue Display:
Volume 23, Issue 2 (2022)
Year:
2022
Volume:
23
Issue:
2
Issue Sort Value:
2022-0023-0002-0000
Page Start:
193
Page End:
195
Publication Date:
2022-02
Subjects:
Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005
Journal URLs:
http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S1470-2045(21)00715-4 ↗
Languages:
English
ISSNs:
1470-2045
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
20676.xml